Document is current
Any future updates will be listed below
-
Authors
Rodríguez-Lorca, Raquel https://orcid.org/0000-0001-6027-0422
Román, Ramón
Beteta-Göbel, Roberto
Torres, Manuel
Lladó, Victoria
Escribá, Pablo V.
Fernández-García, Paula
-
Funding
Funding for this research was provided by:
Universitat de Les Illes Balears
- License Information
-
More Information
Article History
Accepted: 19 September 2024
First Online: 14 October 2024
Declarations
:
: All the experimental procedures involving animals were carried out in accordance with the animal welfare guidelines of the European Union (86/609/EEC) and with the authorization of the Institutional Committee for Animal Research at the University of the Balearic Islands (RD 53/2013).
: The authors declare that they agree to submit the article for publication.
: R.R.-L., R.B.-G., M.T., V.L., P.V.E and P.F.-G., declare that they are shareholders in the biotech company, Laminar Pharmaceuticals SA. P.V.E. declares that he is also a shareholder in the biotech companies Pharmaconcept, Neurofix and Ability Therapeutics.
